keyword
https://read.qxmd.com/read/38644824/anticancer-potential-of-grifolin-in-lung-cancer-treatment-through-pi3k-akt-pathway-inhibition
#1
JOURNAL ARTICLE
Li Wang, Yongjun Wang, Zexu Wang, Xiuwei Zhang, Huayong Chen, Qiuqi Lin, Xin Wang, Yuting Wen, Xia Pan, Zhongliang Guo, Bing Wan
OBJECTIVE: Grifolin is a natural secondary metabolite isolated from edible fruiting bodies of the mushroom Albatrellus confluens . Grifolin has antitumor activities in several types of cancer. We aimed to determine the effects of grifolin on lung cancer. METHODS: We determined the proliferation, migration, invasion, and apoptosis of lung cancer cells using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Ethynyl deoxyuridine, colony formation, wound scratch, transwell, flow cytometry, and xenograft mouse assays...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38642059/investigating-the-role-of-klf6-in-the-growth-of-bovine-preadipocytes-using-transcriptomic-analyses-to-understand-beef-quality
#2
JOURNAL ARTICLE
Sayed Haidar Abbas Raza, Ruimin Zhong, Xiaoqun Wei, Gang Zhao, Linsen Zan, Sameer D Pant, Nicola M Schreurs, Hongtao Lei
Intramuscular fat is a crucial determinant of carcass quality traits like tenderness and taste, which in turn is influenced by the proliferation of intramuscular preadipocytes. This study aimed to investigate the Krüppel-like factor 6 (KLF6)-mediated proliferation of bovine preadipocytes and identify underlying molecular mechanisms. Down-regulation of KLF6 by siKLF6 resulted in a significant ( p < 0.01) suppression of cell cycle-related genes including CDK1, MCM6, ZNF4, PCNA, CDK2, CCNB1, and CDK6. Conversely, the expression level of p27 was significantly ( p < 0...
April 20, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38641704/narazaciclib-a-novel-multi-kinase-inhibitor-with-potent-activity-against-csf1r-flt3-and-cdk6-shows-strong-anti-aml-activity-in-defined-preclinical-models
#3
JOURNAL ARTICLE
Tao Yang, Hang Ke, Jinping Liu, Xiaoyu An, Jia Xue, Jinying Ning, Feng Hao, Lingxin Xiong, Cen Chen, Yueying Wang, Jia Zheng, Bing Gao, Zhengzheng Bao, Kefeng Gong, Lei Zhang, Faming Zhang, Sheng Guo, Qi-Xiang Li
CSF1R is a receptor tyrosine kinase responsible for the growth/survival/polarization of macrophages and overexpressed in some AML patients. We hypothesized that a novel multi-kinase inhibitor (TKi), narazaciclib (HX301/ON123300), with high potency against CSF1R (IC50  ~ 0.285 nM), would have anti-AML effects. We tested this by confirming HX301's high potency against CSF1R (IC50  ~ 0.285 nM), as well as other kinases, e.g. FLT3 (IC50 of ~ 19.77 nM) and CDK6 (0...
April 19, 2024: Scientific Reports
https://read.qxmd.com/read/38639656/-lncrna-rpl22p1-201-affects-prostate-cancer-cell-proliferation-cell-cycle-and-sensitivity-to-docetaxel-by-regulating-mir-216b-5p-expression
#4
JOURNAL ARTICLE
Chao Yang, Jian-Guo Xue
OBJECTIVE: Exploring the effects and mechanisms of long non coding RNA (lncRNA) RPL22P1-201 on prostate cancer cell proliferation, cell cycle, and docetaxel sensitivity by regulating miR-216b-5p expression. METHODS: The Cancer LncRNA Census database was used to analyze the differential expression of RPL22P1-201 between prostate cancer tissue and normal tissue. Real time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression level of RPL22P1-201 in prostate cancer cell lines (DU-145, C4-2B, PC3, 22Rv1, LNCaP) and normal prostate epithelial cells (RWPE-1)...
October 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38636406/identifying-pirnas-that-regulate-bap-induced-lung-injuries-a-bottom-up-approach-from-toxicity-pathway-investigation-to-animal-validation
#5
JOURNAL ARTICLE
Qinkai Lei, Chenlong Du, Yumei Ma, Yingqing Shou, Li Chen, Chiyuan Feng, Yuxin Zheng, Dianke Yu, Yuan Jin
PIWI-interacting RNAs (piRNAs) is an emerging class of small non-coding RNAs that has been recently reported to have functions in infertility, tumorigenesis, and multiple diseases in humans. Previously, 5 toxicity pathways were proposed from hundreds of toxicological studies that underlie BaP-induced lung injuries, and a "Bottom-up" approach was established to identify small non-coding RNAs that drive BaP-induced pulmonary effects by investigating the activation of these pathways in vitro, and the expression of the candidate microRNAs were validated in tissues of patients with lung diseases from publications...
April 17, 2024: Ecotoxicology and Environmental Safety
https://read.qxmd.com/read/38633613/network-pharmacology-and-molecular-docking-reveal-the-mechanisms-of-curcumin-activity-against-esophageal-squamous-cell-carcinoma
#6
JOURNAL ARTICLE
Jian Wang, Zhilong Zhang, Qian Li, Zilong Hu, Yuan Chen, Hao Chen, Wei Cai, Qiancheng Du, Peng Zhang, Dian Xiong, Shugao Ye
Background: Curcumin (CUR), an effective traditional Chinese medicinal extract, displays good anti-cancer activity against various cancers. Nevertheless, the impacts and fundamental mechanisms of CUR to treat esophageal squamous cell carcinoma (ESCC) yet to be comprehensively clarified. This study examined the suppressive impacts of CUR on ESCC. Methods: For a comprehensive understanding of the effect of CUR in ESCC. The CUR targets and ESCC-related genes were identified respectively, and the intersection targets between CUR and ESCC were acquired...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38626179/circprmt5-promotes-progression-of-osteosarcoma-by-recruiting-cnbp-to-regulate-the-translation-and-stability-of-cdk6-mrna
#7
JOURNAL ARTICLE
Yunlu Liu, Hongyan Jiang, Keli Hu, Hui Zou, Weiguo Zhang, Jiangtao Liu, Xiaofei Jian
Research has demonstrated that circular RNAs (circRNAs) exert critical functions in the occurrence and progression of numerous malignant tumors. CircPRMT5 was recently reported to be involved in the pathogenesis of cancers. However, the potential role of circPRMT5 in osteosarcoma needs further investigation. In present study, our results suggested that circPRMT5 was highly upregulated in osteosarcoma cells and mainly localizes in the cytoplasm. CircPRMT5 promoted the proliferation, migration and invasion capacities of osteosarcoma cells, and suppressed cell apoptosis...
2024: PloS One
https://read.qxmd.com/read/38619193/association-between-cdk4-6-inhibitors-and-drug-related-osteonecrosis-of-the-jaw-a-pharmacoepidemiological-study-using-the-fda-adverse-events-reporting-system
#8
JOURNAL ARTICLE
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
The most common toxicities associated with cyclin-dependent kinase (CDK) 4/6 inhibitor therapy include decreased leukopenia and neutropenia due to the inhibition of CDK6 of leukocyte and neutrophil precursors in bone marrow. These hematological toxicities are more commonly observed with palbociclib administration than with abemaciclib administration, which is approximately 13 times more selective against CDK4 than CDK6. Thus, even though both successfully inhibit CDK4/6, the side effects of palbociclib and abemaciclib differ due to differences in selectivity...
April 15, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38619074/ring-contracted-artemisinin-derivatives-as-novel-cdk4-6-inhibitors-synthesis-and-anti-breast-cancer-evaluation
#9
JOURNAL ARTICLE
Junjie Zhu, Yi Ai, Junhui Wu, Changgaung Zeng, Zhen Cui, Zhengping Zhang, Jiayi Zhu, Changqi Wang, Hang Zhong
The endoperoxide group of artemisinins is a universally accepted essential group for their anti-cancer effects. In this work, a series of D-ring-contracted artemisinin derivatives were constructed by combining ring-contracted artemisinin core with the fragments of functional heterocyclic molecules or classical CDK4/6 inhibitors to identify more efficacious breast cancer treatment agents. Twenty-six novel hybridized molecules were synthesized and characterized by HRMS, IR, 1H NMR and 13C NMR data. In antiproliferative activities and kinase inhibitory effects assays, we found that the antiproliferative effects of B01 were close to positive controls Palbociclib, with GI50 values of 4...
April 15, 2024: Chemistry & Biodiversity
https://read.qxmd.com/read/38612869/the-clinicopathological-significance-of-the-cyclin-d1-e1-cyclin-dependent-kinase-cdk2-4-6-retinoblastoma-rb1-prb1-pathway-in-epithelial-ovarian-cancers
#10
JOURNAL ARTICLE
Ayat Lashen, Mashael Algethami, Shatha Alqahtani, Ahmed Shoqafi, Amera Sheha, Jennie N Jeyapalan, Nigel P Mongan, Emad A Rakha, Srinivasan Madhusudan
Cyclin-dependent kinases (CDK2, CDK4, CDK6), cyclin D1, cyclin E1 and phosphorylated retinoblastoma (pRB1) are key regulators of the G1/S cell cycle checkpoint and may influence platinum response in ovarian cancers. CDK2/4/6 inhibitors are emerging targets in ovarian cancer therapeutics. In the current study, we evaluated the prognostic and predictive significance of the CDK2/4/6-cyclin D1/E1-pRB1 axis in clinical ovarian cancers (OC). The CDK2/4/6, cyclin D1/E1 and RB1/pRB1 protein expression were investigated in 300 ovarian cancers and correlated with clinicopathological parameters and patient outcomes...
April 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612399/vitexicarpin-induces-apoptosis-and-inhibits-metastatic-properties-via-the-akt-pras40-pathway-in-human-osteosarcoma
#11
JOURNAL ARTICLE
Hyung-Mun Yun, Hyun Sook Kwon, Joon Yeop Lee, Kyung-Ran Park
Osteosarcoma, which has poor prognosis after metastasis, is the most common type of bone cancer in children and adolescents. Therefore, plant-derived bioactive compounds are being actively developed for cancer therapy. Artemisia apiacea Hance ex Walp. is a traditional medicinal plant native to Eastern Asia, including China, Japan, and Korea. Vitexicarpin (Vitex), derived from A. apiacea, has demonstrated analgesic, anti-inflammatory, antitumour, and immunoregulatory properties; however, there are no published studies on Vitex isolated from the aerial parts of A...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610989/synergistic-effects-of-the-rar-alpha-agonist-tamibarotene-and-the-menin-inhibitor-revumenib-in-acute-myeloid-leukemia-cells-with-kmt2a-rearrangement-or-npm1-mutation
#12
JOURNAL ARTICLE
Maximilian Fleischmann, Julia Bechwar, Diana Voigtländer, Mike Fischer, Ulf Schnetzke, Andreas Hochhaus, Sebastian Scholl
Inhibition of menin in acute myeloid leukemia (AML) harboring histone-lysine- N -methyltransferase 2A rearrangement (KMT2Ar) or the mutated Nucleophosmin gene (NPM1c) is considered a novel and effective treatment approach in these patients. However, rapid acquisition of resistance mutations can impair treatment success. In patients with elevated retinoic acid receptor alpha (RARA) expression levels, promising effects are demonstrated by the next-generation RAR alpha agonist tamibarotene, which restores differentiation or induces apoptosis...
March 28, 2024: Cancers
https://read.qxmd.com/read/38596294/microrna-34a-5p-a-pivotal-therapeutic-target-in-gallbladder-cancer
#13
JOURNAL ARTICLE
Takashi Oda, Koichiro Tsutsumi, Taisuke Obata, Eijiro Ueta, Tatsuya Kikuchi, Soichiro Ako, Yuki Fujii, Tatsuhiro Yamazaki, Daisuke Uchida, Kazuyuki Matsumoto, Shigeru Horiguchi, Hironari Kato, Hiroyuki Okada, Ryota Chijimatsu, Motoyuki Otsuka
Gallbladder cancer incidence has been increasing globally, and it remains challenging to expect long prognosis with the current systemic chemotherapy. We identified a novel nucleic acid-mediated therapeutic target against gallbladder cancer by using innovative organoid-based gallbladder cancer models generated from Kras LSL-G12D/+ ; Trp53 f/f mice. Using comprehensive microRNA expression analyses and a bioinformatics approach, we identified significant microRNA-34a-5p downregulation in both murine gallbladder cancer organoids and resected human gallbladder cancer specimens...
March 21, 2024: Mol Ther Oncol
https://read.qxmd.com/read/38583080/a-narrative-review-on-therapeutic-potential-of-naringenin-in-colorectal-cancer-focusing-on-molecular-and-biochemical-processes
#14
REVIEW
Mohammad Yasin Zamanian, Maryam Golmohammadi, Bekhzod Abdullaev, María Olalla García, Adeeb Abdulally Abdulhussien Alazbjee, Abhinav Kumar, Sameer S Mohaamed, Beneen M Hussien, Fattaneh Khalaj, Seyede Mahsa Hodaei, Niyousha Shirsalimi, Gervason Moriasi
Colorectal cancer (CRC) is a common and highly metastatic cancer affecting people worldwide. Drug resistance and unwanted side effects are some of the limitations of current treatments for CRC. Naringenin (NAR) is a naturally occurring compound found in abundance in various citrus fruits such as oranges, grapefruits, and tomatoes. It possesses a diverse range of pharmacological and biological properties that are beneficial for human health. Numerous studies have highlighted its antioxidant, anticancer, and anti-inflammatory activities, making it a subject of interest in scientific research...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38577886/retraction-downregulation-of-mir-218-by-nicotine-promotes-cell-proliferation-through-targeting-cdk6-in-non-small-cell-lung-cancer
#15
(no author information available yet)
Downregulation of miR-218 by nicotine promotes cell proliferation through targeting CDK6 in non-small cell lung cancer, by Zhen Liu, Cuiling Lu, Guanren Zhao, Xue Han, Kaisheng Dong, Chuanhai Wang, Jing-Zhi Guan, Zhongyuan Wang, J Cell Biochem. 2019; 120: 18370-18377: The above article, published online on 12 June 2019 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/full/10.1002/jcb.29148) has been retracted by agreement between the authors, the journal's Editor in Chief, Christian Behl, and Wiley Periodicals LLC...
April 5, 2024: Journal of Cellular Biochemistry
https://read.qxmd.com/read/38565061/dmc-siercc2-hybrid-nanoparticle-enhances-trail-sensitivity-by-inducing-cell-cycle-arrest-for-glioblastoma-treatment
#16
JOURNAL ARTICLE
Meihui Song, Tengfei Wang, Tao Liu, Ting Lei, Xu Teng, Qian Peng, Qihui Zhu, Feng Chen, Guifang Zhao, Kaishu Li, Ling Qi
ERCC2 plays a pivotal role in DNA damage repair, however, its specific function in cancer remains elusive. In this study, we made a significant breakthrough by discovering a substantial upregulation of ERCC2 expression in glioblastoma (GBM) tumor tissue. Moreover, elevated levels of ERCC2 expression were closely associated with poor prognosis. Further investigation into the effects of ERCC2 on GBM revealed that suppressing its expression significantly inhibited malignant growth and migration of GBM cells, while overexpression of ERCC2 promoted tumor cell growth...
April 1, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38554981/antiprogestins-for-breast-cancer-treatment-we-are-almost-ready
#17
JOURNAL ARTICLE
Andrés Elia, Gabriela Pataccini, Leo Saldain, Luisa Ambrosio, Claudia Lanari, Paola Rojas
The development of antiprogestins was initially a gynecological purpose. However, since mifepristone was developed, its application for breast cancer treatment was immediately proposed. Later, new compounds with lower antiglucocorticoid and antiandrogenic effects were developed to be applied to different pathologies, including breast cancer. We describe herein the studies performed in the breast cancer field with special focus on those reported in recent years, ranging from preclinical biological models to those carried out in patients...
March 28, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38552377/epigallocatechin-gallate-suppresses-mitotic-clonal-expansion-and-adipogenic-differentiation-of-preadipocytes-through-impeding-jak2-stat3-mediated-transcriptional-cascades
#18
JOURNAL ARTICLE
He Peng, Xiaojian Lin, Ying Wang, Jiajun Chen, Qian Zhao, Shengjia Chen, Qi Cheng, Chaojie Chen, Tingting Sang, Hongyu Zhou, Jun Xiao, Wen Wang, Liu Fang, Xingya Wang
BACKGROUND: Mitotic clonal expansion (MCE) is a prerequisite for preadipocyte differentiation and adipogenesis. Epigallocatechin gallate (EGCG) has been shown to inhibit preadipocyte differentiation. However, the exact molecular mechanisms are still elusive. PURPOSE: This study investigated whether EGCG could inhibit adipogenesis and lipid accumulation by regulating the cell cycle in the MCE phase of adipogenesis and its underlying molecular mechanisms. METHOD: 3T3-L1 preadipocytes were induced to differentiate by a differentiation cocktail (DMI) and were treated with EGCG (25-100 μM) for 9, 18, and 24 h to examine the effect on MCE, or eight days to examine the effect on terminal differentiation...
March 22, 2024: Phytomedicine
https://read.qxmd.com/read/38549490/deciphering-congenital-heart-defects-facial-dysmorphism-and-intellectual-developmental-disorder-chdfidd-associated-with-constitutional-cdk13-pathogenic-variants-case-report-and-literature-review
#19
Katarzyna Wojciechowska, Michał Kwaśny, Aleksandra Pietrzyk, Monika Lejman
There are 21 human cyclin-dependent kinases which are involved in regulation of the cell cycle, transcription, RNA splicing, apoptosis and neurogenesis. Five of them: CDK4, CDK5, CDK6, CDK10 and CDK13 are associated with human phenotypes. To date, only 62 patients have been presented with mutated CDK13 gene. Those patients had developmental delay, dysmorphic facial features, feeding difficulties, different structural heart and brain defects. 36 of them had missense mutation affecting the protein kinase domain of CDK13...
March 25, 2024: Annals of Agricultural and Environmental Medicine: AAEM
https://read.qxmd.com/read/38540112/an-italian-real-world-study-highlights-the-importance-of-some-clinicopathological-characteristics-useful-in-identifying-metastatic-breast-cancer-patients-resistant-to-cdk4-6-inhibitors-and-hormone-therapy
#20
JOURNAL ARTICLE
Roberta Maltoni, Andrea Roncadori, William Balzi, Massimiliano Mazza, Fabio Nicolini, Michela Palleschi, Paola Ulivi, Sara Bravaccini
Background: Cyclin-dependent kinase 4 and 6 (CDK4 and CDK6) inhibitors have changed the therapeutic management of hormone receptor-positive (HR+) metastatic breast cancer (mBC) by targeting the cell cycle machinery and overcoming endocrine resistance. However, a large number of patients present disease progression due to cancer cells resisting CDK4/6 inhibitors. Our research considers which clinicopathological characteristics could be useful in identifying patients who might respond to CDK4/6 inhibitors by analyzing a retrospective case series of patients with HR+ mBC who were treated with hormone therapy plus CDK4/6 inhibitors...
February 22, 2024: Biomedicines
keyword
keyword
114006
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.